Instead of a team of writers spending months manually assembling a drug approval document, Ritivel's AI drafts the entire thing in minutes and shows exactly where every fact came from.

Ritivel's core engineering use case centers on proprietary large language models fine-tuned exclusively on life sciences regulatory data—clinical study reports, common technical documents, investigational new drug applications, and biologics license applications. Unlike generic LLMs, these domain-specific models understand the precise structure, terminology, and regulatory expectations of each document type. The platform's AI agents ingest raw clinical data, statistical outputs, and protocol documents, then generate fully formatted drafts directly within Microsoft Word. Critically, every claim, data point, and assertion in the output is traced at the word level back to its source document, enabling regulatory reviewers to verify accuracy instantly. The system produces deterministic outputs—identical inputs always yield identical documents—eliminating the variability and subjective interpretation inherent in human drafting. This combination of speed, traceability, and reproducibility transforms the regulatory writing bottleneck from a months-long, error-prone process into a rapid, auditable, and consistent workflow, directly accelerating drug approval timelines and reducing the cost of regulatory operations.

It's like having a paralegal who can write an entire FDA filing in the time it takes you to brew coffee—and who highlights exactly which page of evidence backs up every single sentence.

Instead of manually hunting through thousands of pages of past submissions to find a relevant precedent or data point, Ritivel's AI instantly searches everything and pulls exactly what you need.

Ritivel's data-focused use case leverages advanced natural language processing to index, search, and extract structured information from vast repositories of regulatory documents—spanning prior submissions, clinical study reports, regulatory agency feedback letters, and internal SOPs. Traditional regulatory intelligence requires analysts to manually review hundreds or thousands of documents to locate relevant precedents, identify evolving agency expectations, or cross-reference data points across submissions. Ritivel's NLP engine understands regulatory-specific terminology, document hierarchies (e.g., eCTD module structures), and contextual relationships between data elements. Users can issue natural language queries—such as "find all primary efficacy endpoints for Phase III oncology trials submitted to FDA in the last 3 years"—and receive precise, source-cited results in seconds. The system also supports automated cross-referencing, flagging inconsistencies between documents (e.g., a protocol amendment that conflicts with a CSR narrative) and surfacing gaps in submission readiness. By transforming unstructured regulatory archives into a queryable, AI-indexed knowledge base, Ritivel dramatically accelerates strategic decision-making around submission timing, content strategy, and regulatory risk assessment.

It's like replacing a room full of filing cabinets and a magnifying glass with a search engine that actually understands what "bioequivalence" means and where you last mentioned it.

Instead of a project manager chasing dozens of people via email for missing documents and approvals, Ritivel's AI agents automatically track what's needed, remind the right people, and assemble everything on schedule.

Ritivel's operations use case deploys AI agents that automate the end-to-end workflow of regulatory submission assembly—a process traditionally managed through manual project tracking, email chains, and spreadsheet-based checklists. These agents integrate with Microsoft Outlook, SharePoint, and Veeva Vault to monitor document readiness across distributed teams, automatically identify missing components (e.g., an unsigned investigator's brochure or an outdated statistical analysis plan), and trigger targeted reminders to responsible stakeholders. The agents understand submission timelines and regulatory milestones, dynamically reprioritizing tasks when delays occur and escalating blockers to project leads. Beyond simple reminders, the system performs intelligent document gathering—pulling the latest approved versions from connected repositories, verifying version control, and flagging discrepancies between document metadata and submission requirements. As documents are finalized, the agents assemble them into the correct submission structure (e.g., eCTD folder hierarchy), perform pre-submission quality checks, and generate readiness dashboards for regulatory affairs leadership. This agentic approach transforms submission operations from a reactive, labor-intensive coordination exercise into a proactive, AI-managed workflow that ensures nothing falls through the cracks and submissions hit their target dates consistently.

It's like having a hyper-organized wedding planner who never forgets a vendor, never loses an RSVP, and somehow gets your uncle to return his suit rental on time—except the wedding is an FDA submission.